ImpriMed

About:

ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies

Website: https://www.imprimedicine.com

Twitter/X: Imprimedicine

Top Investors: Plug and Play, Korea Development Bank, Pear VC, Draper Associates, SBVA

Description:

ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology provides precision medicine techniques that allow veterinary oncologists to find appropriate anticancer drugs by developing a patient-derived database for pet cancer treatment that can eventually be translated into human cancer care, allowing doctors to decide on a final treatment regimen based on a data-driven prediction of response success in each individual patient's body.